SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Corporation, Eli Lilly and Company Release: EU Approval Granted for Trajenta® (linagliptin) Tablets as Add-on Therapy to Insulin in Adults With Type 2 Diabetes